phosphoenolpyruvate has been researched along with Heart Valve Diseases in 1 studies
Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuzaki, K | 1 |
| Takano, H | 1 |
| Tokunaga, K | 1 |
| Inaba, S | 1 |
| Hamasaki, N | 1 |
1 other study available for phosphoenolpyruvate and Heart Valve Diseases
| Article | Year |
|---|---|
Clinical application of phosphoenolpyruvate (PEP) to autologous transfusion of patients with open heart surgery.
Topics: Adult; Blood Preservation; Blood Transfusion, Autologous; Cardiac Surgical Procedures; Cryopreservat | 1993 |